Complete BIAF Stock Valuation Analysis
Comprehensive intrinsic value analysis using 2 different methodologies
BIAF DCF Analysis
BIAF (bioAffinity Technologies, Inc.) discounted cash flow analysis with multiple scenarios, growth assumptions, and terminal value calculations
Financial Projections
| Metrics | 2022 (Historical) | 2023 (Historical) | 2024 (Historical) | 2025 (Projected) | 2026 (Projected) | 2027 (Projected) | 2028 (Projected) | 2029 (Projected) |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.8K | $2.5M | $9.4M | $11.7M | $14.6M | $18.3M | $22.9M | $28.6M |
| Revenue Growth % | - | 52627.4% | 269.7% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% |
| EBIT | $-4.0M | $-8.0M | $-9.0M | $585.1K | $731.4K | $914.3K | $1.1M | $1.4M |
| EBIT Margin % | -83511.5% | -314.8% | -95.6% | 5.0% | 5.0% | 5.0% | 5.0% | 5.0% |
| Tax Rate % | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% |
| NOPAT | $-3.0M | $-6.0M | $-6.7M | $438.8K | $548.6K | $685.7K | $857.1K | $1.1M |
| NOPAT Margin % | -62633.6% | -236.1% | -71.7% | 3.8% | 3.8% | 3.8% | 3.8% | 3.8% |
| Capex | $220.0K | $22.9K | $79.1K | $117.0K | $146.3K | $182.9K | $228.6K | $285.7K |
| Capex / Revenue % | 4580.2% | 0.9% | 0.8% | 1.0% | 1.0% | 1.0% | 1.0% | 1.0% |
| Depreciation | $10.2K | $249.6K | $605.6K | $8.9M | $11.1M | $13.9M | $17.4M | $21.7M |
| D&A / Revenue % | 212.0% | 9.9% | 6.5% | 76.1% | 76.1% | 76.1% | 76.1% | 76.1% |
| Change in NWC | $22.4M | $-9.1M | $-2.1M | $117.0K | $146.3K | $182.9K | $228.6K | $285.7K |
| NWC Change / Revenue % | 466881.1% | -359.3% | -22.8% | 1.0% | 1.0% | 1.0% | 1.0% | 1.0% |
| Unlevered FCF | $-25.6M | $3.3M | $-4.1M | $9.1M | $11.4M | $14.2M | $17.8M | $22.2M |
| UFCF % Chg. | - | 113.0% | -221.2% | 324.8% | 25.0% | 25.0% | 25.0% | 25.0% |
| FCF / Revenue % | -533882.9% | 132.1% | -43.3% | 77.9% | 77.9% | 77.9% | 77.9% | 77.9% |
| Discount Factor | - | - | - | 0.879 | 0.772 | 0.679 | 0.596 | 0.524 |
| Present Value of FCF | - | - | - | $8.0M | $8.8M | $9.7M | $10.6M | $11.7M |
| Sum of PV of UFCF | - | - | - | $8.0M | $16.8M | $26.5M | $37.1M | $48.7M |
WACC Calculation
Weighted Average Cost of Capital used for discounting cash flows.
| WACC Calculation | Value |
|---|---|
| Cost of Debt | 6.8% |
| Tax Rate | 25.0% |
| After Tax Cost of Debt | 5.1% |
| Risk Free Rate | 4.26% |
| Market Risk Premium | 4.3% |
| Beta | 2.56 |
| Cost of Equity | 15.3% |
| Total Debt | $1.5M |
| Market Cap | $8.5M |
| Total Capital | $10.0M |
| Debt Weighting | 15.0% |
| Equity Weighting | 85.0% |
| WACC | 13.8% |
Terminal Value
Choose between perpetuity growth or exit multiple methods.
| Terminal Value Calculation | Value |
|---|---|
| Terminal Growth Rate | 2.5% |
| Final Year FCF | $22.2M |
| Terminal Value | $201.9M |
| PV of Terminal Value | $105.8M |
| Cumulative PV of UFCF | $48.7M |
| Net Debt | $395.9K |
| Equity Value | $154.2M |
| Shares Outstanding | 12.1M |
| Implied Share Price | $13 |
| Current Share Price | $0 |
| Implied Upside/(Downside) | +4158.4% |
Valuation Summary
$12.71
Implied Price
$0.30
Current Price
+4158.4%
Upside/Downside
13.8%
WACC
BIAF Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 8 peer companies in Healthcare
P/E Ratio
$0.00
-100.0%
Peer Median: 0.0x
EV/EBITDA
$0.00
-100.0%
Peer Median: 0.0x
P/S Ratio
$0.30
+0.0%
Peer Median: 1.0x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for BIAF's business model and current situation.
Multiple Comparison
| Multiple | BIAF Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -0.5x | 0.0x | 0.0x | -Infinity% | Undervalued |
| EV/EBITDA | Infinityx | 0.0x | 0.0x | Infinity% | Overvalued |
| P/S Ratio | 1.0x | 1.0x | 0.8x | 0.0% | Fair Value |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.01B | 0.0x | 0.0x | 0.0x | |
| $0.02B | 0.0x | 0.0x | 1.1x | |
| $0.01B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 0.0x | 0.0x | 0.3x | |
| $0.01B | 0.0x | 0.0x | 1.0x | |
| $0.01B | 0.0x | 0.0x | 657.9x | |
| $0.01B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 0.0x | 0.0x | 304.9x |